I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE
Table 1: World Current & Future Analysis for Women's Health
Therapeutics by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2020 through 2027 and % CAGR

Table 2: World Historic Review for Women's Health Therapeutics
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 3: World 15-Year Perspective for Women's Health
Therapeutics by Geographic Region - Percentage Breakdown of
Value Sales for USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets for
Years 2012, 2020 & 2027

Table 4: World Current & Future Analysis for Postmenopausal
Osteoporosis by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2020 through 2027 and % CAGR

Table 5: World Historic Review for Postmenopausal Osteoporosis
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 6: World 15-Year Perspective for Postmenopausal
Osteoporosis by Geographic Region - Percentage Breakdown of
Value Sales for USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa for Years
2012, 2020 & 2027

Table 7: World Current & Future Analysis for Hormonal
Infertility by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2020 through 2027 and % CAGR

Table 8: World Historic Review for Hormonal Infertility by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 9: World 15-Year Perspective for Hormonal Infertility by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 10: World Current & Future Analysis for Polycystic Ovary
Syndrome by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2020 through 2027 and % CAGR

Table 11: World Historic Review for Polycystic Ovary Syndrome
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 12: World 15-Year Perspective for Polycystic Ovary
Syndrome by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific,
Latin America, Middle East and Africa for Years 2012, 2020 &
2027

Table 13: World Current & Future Analysis for Endometriosis by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027 and % CAGR

Table 14: World Historic Review for Endometriosis by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 15: World 15-Year Perspective for Endometriosis by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 16: World Current & Future Analysis for Contraceptives by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027 and % CAGR

Table 17: World Historic Review for Contraceptives by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 18: World 15-Year Perspective for Contraceptives by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 19: World Current & Future Analysis for Menopause by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027 and % CAGR

Table 20: World Historic Review for Menopause by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 21: World 15-Year Perspective for Menopause by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2012, 2020 & 2027

Table 22: World Current & Future Analysis for Other
Applications by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2020 through 2027 and % CAGR

Table 23: World Historic Review for Other Applications by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 24: World 15-Year Perspective for Other Applications by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

III. MARKET ANALYSIS

UNITED STATES
Table 25: USA Current & Future Analysis for Women's Health
Therapeutics by Application - Postmenopausal Osteoporosis,
Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis,
Contraceptives, Menopause and Other Applications - Independent
Analysis of Annual Sales in US$ Million for the Years 2020
through 2027 and % CAGR

Table 26: USA Historic Review for Women's Health Therapeutics
by Application - Postmenopausal Osteoporosis, Hormonal
Infertility, Polycystic Ovary Syndrome, Endometriosis,
Contraceptives, Menopause and Other Applications Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 27: USA 15-Year Perspective for Women's Health
Therapeutics by Application - Percentage Breakdown of Value
Sales for Postmenopausal Osteoporosis, Hormonal Infertility,
Polycystic Ovary Syndrome, Endometriosis, Contraceptives,
Menopause and Other Applications for the Years 2012, 2020 &
2027

CANADA
Table 28: Canada Current & Future Analysis for Women's Health
Therapeutics by Application - Postmenopausal Osteoporosis,
Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis,
Contraceptives, Menopause and Other Applications - Independent
Analysis of Annual Sales in US$ Million for the Years 2020
through 2027 and % CAGR

Table 29: Canada Historic Review for Women's Health
Therapeutics by Application - Postmenopausal Osteoporosis,
Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis,
Contraceptives, Menopause and Other Applications Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 30: Canada 15-Year Perspective for Women's Health
Therapeutics by Application - Percentage Breakdown of Value
Sales for Postmenopausal Osteoporosis, Hormonal Infertility,
Polycystic Ovary Syndrome, Endometriosis, Contraceptives,
Menopause and Other Applications for the Years 2012, 2020 &
2027

JAPAN
Table 31: Japan Current & Future Analysis for Women's Health
Therapeutics by Application - Postmenopausal Osteoporosis,
Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis,
Contraceptives, Menopause and Other Applications - Independent
Analysis of Annual Sales in US$ Million for the Years 2020
through 2027 and % CAGR

Table 32: Japan Historic Review for Women's Health Therapeutics
by Application - Postmenopausal Osteoporosis, Hormonal
Infertility, Polycystic Ovary Syndrome, Endometriosis,
Contraceptives, Menopause and Other Applications Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 33: Japan 15-Year Perspective for Women's Health
Therapeutics by Application - Percentage Breakdown of Value
Sales for Postmenopausal Osteoporosis, Hormonal Infertility,
Polycystic Ovary Syndrome, Endometriosis, Contraceptives,
Menopause and Other Applications for the Years 2012, 2020 &
2027

CHINA
Table 34: China Current & Future Analysis for Women's Health
Therapeutics by Application - Postmenopausal Osteoporosis,
Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis,
Contraceptives, Menopause and Other Applications - Independent
Analysis of Annual Sales in US$ Million for the Years 2020
through 2027 and % CAGR

Table 35: China Historic Review for Women's Health Therapeutics
by Application - Postmenopausal Osteoporosis, Hormonal
Infertility, Polycystic Ovary Syndrome, Endometriosis,
Contraceptives, Menopause and Other Applications Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 36: China 15-Year Perspective for Women's Health
Therapeutics by Application - Percentage Breakdown of Value
Sales for Postmenopausal Osteoporosis, Hormonal Infertility,
Polycystic Ovary Syndrome, Endometriosis, Contraceptives,
Menopause and Other Applications for the Years 2012, 2020 &
2027

EUROPE
Table 37: Europe Current & Future Analysis for Women's Health
Therapeutics by Geographic Region - France, Germany, Italy, UK,
Spain, Russia and Rest of Europe Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2020 through 2027 and
% CAGR

Table 38: Europe Historic Review for Women's Health
Therapeutics by Geographic Region - France, Germany, Italy, UK,
Spain, Russia and Rest of Europe Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 39: Europe 15-Year Perspective for Women's Health
Therapeutics by Geographic Region - Percentage Breakdown of
Value Sales for France, Germany, Italy, UK, Spain, Russia and
Rest of Europe Markets for Years 2012, 2020 & 2027

Table 40: Europe Current & Future Analysis for Women's Health
Therapeutics by Application - Postmenopausal Osteoporosis,
Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis,
Contraceptives, Menopause and Other Applications - Independent
Analysis of Annual Sales in US$ Million for the Years 2020
through 2027 and % CAGR

Table 41: Europe Historic Review for Women's Health
Therapeutics by Application - Postmenopausal Osteoporosis,
Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis,
Contraceptives, Menopause and Other Applications Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 42: Europe 15-Year Perspective for Women's Health
Therapeutics by Application - Percentage Breakdown of Value
Sales for Postmenopausal Osteoporosis, Hormonal Infertility,
Polycystic Ovary Syndrome, Endometriosis, Contraceptives,
Menopause and Other Applications for the Years 2012, 2020 &
2027

FRANCE
Table 43: France Current & Future Analysis for Women's Health
Therapeutics by Application - Postmenopausal Osteoporosis,
Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis,
Contraceptives, Menopause and Other Applications - Independent
Analysis of Annual Sales in US$ Million for the Years 2020
through 2027 and % CAGR

Table 44: France Historic Review for Women's Health
Therapeutics by Application - Postmenopausal Osteoporosis,
Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis,
Contraceptives, Menopause and Other Applications Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 45: France 15-Year Perspective for Women's Health
Therapeutics by Application - Percentage Breakdown of Value
Sales for Postmenopausal Osteoporosis, Hormonal Infertility,
Polycystic Ovary Syndrome, Endometriosis, Contraceptives,
Menopause and Other Applications for the Years 2012, 2020 &
2027

GERMANY
Table 46: Germany Current & Future Analysis for Women's Health
Therapeutics by Application - Postmenopausal Osteoporosis,
Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis,
Contraceptives, Menopause and Other Applications - Independent
Analysis of Annual Sales in US$ Million for the Years 2020
through 2027 and % CAGR

Table 47: Germany Historic Review for Women's Health
Therapeutics by Application - Postmenopausal Osteoporosis,
Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis,
Contraceptives, Menopause and Other Applications Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 48: Germany 15-Year Perspective for Women's Health
Therapeutics by Application - Percentage Breakdown of Value
Sales for Postmenopausal Osteoporosis, Hormonal Infertility,
Polycystic Ovary Syndrome, Endometriosis, Contraceptives,
Menopause and Other Applications for the Years 2012, 2020 &
2027

ITALY
Table 49: Italy Current & Future Analysis for Women's Health
Therapeutics by Application - Postmenopausal Osteoporosis,
Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis,
Contraceptives, Menopause and Other Applications - Independent
Analysis of Annual Sales in US$ Million for the Years 2020
through 2027 and % CAGR

Table 50: Italy Historic Review for Women's Health Therapeutics
by Application - Postmenopausal Osteoporosis, Hormonal
Infertility, Polycystic Ovary Syndrome, Endometriosis,
Contraceptives, Menopause and Other Applications Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 51: Italy 15-Year Perspective for Women's Health
Therapeutics by Application - Percentage Breakdown of Value
Sales for Postmenopausal Osteoporosis, Hormonal Infertility,
Polycystic Ovary Syndrome, Endometriosis, Contraceptives,
Menopause and Other Applications for the Years 2012, 2020 &
2027

UNITED KINGDOM
Table 52: UK Current & Future Analysis for Women's Health
Therapeutics by Application - Postmenopausal Osteoporosis,
Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis,
Contraceptives, Menopause and Other Applications - Independent
Analysis of Annual Sales in US$ Million for the Years 2020
through 2027 and % CAGR

Table 53: UK Historic Review for Women's Health Therapeutics by
Application - Postmenopausal Osteoporosis, Hormonal
Infertility, Polycystic Ovary Syndrome, Endometriosis,
Contraceptives, Menopause and Other Applications Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 54: UK 15-Year Perspective for Women's Health
Therapeutics by Application - Percentage Breakdown of Value
Sales for Postmenopausal Osteoporosis, Hormonal Infertility,
Polycystic Ovary Syndrome, Endometriosis, Contraceptives,
Menopause and Other Applications for the Years 2012, 2020 &
2027

SPAIN
Table 55: Spain Current & Future Analysis for Women's Health
Therapeutics by Application - Postmenopausal Osteoporosis,
Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis,
Contraceptives, Menopause and Other Applications - Independent
Analysis of Annual Sales in US$ Million for the Years 2020
through 2027 and % CAGR

Table 56: Spain Historic Review for Women's Health Therapeutics
by Application - Postmenopausal Osteoporosis, Hormonal
Infertility, Polycystic Ovary Syndrome, Endometriosis,
Contraceptives, Menopause and Other Applications Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 57: Spain 15-Year Perspective for Women's Health
Therapeutics by Application - Percentage Breakdown of Value
Sales for Postmenopausal Osteoporosis, Hormonal Infertility,
Polycystic Ovary Syndrome, Endometriosis, Contraceptives,
Menopause and Other Applications for the Years 2012, 2020 &
2027

RUSSIA
Table 58: Russia Current & Future Analysis for Women's Health
Therapeutics by Application - Postmenopausal Osteoporosis,
Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis,
Contraceptives, Menopause and Other Applications - Independent
Analysis of Annual Sales in US$ Million for the Years 2020
through 2027 and % CAGR

Table 59: Russia Historic Review for Women's Health
Therapeutics by Application - Postmenopausal Osteoporosis,
Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis,
Contraceptives, Menopause and Other Applications Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 60: Russia 15-Year Perspective for Women's Health
Therapeutics by Application - Percentage Breakdown of Value
Sales for Postmenopausal Osteoporosis, Hormonal Infertility,
Polycystic Ovary Syndrome, Endometriosis, Contraceptives,
Menopause and Other Applications for the Years 2012, 2020 &
2027

REST OF EUROPE
Table 61: Rest of Europe Current & Future Analysis for Women's
Health Therapeutics by Application - Postmenopausal
Osteoporosis, Hormonal Infertility, Polycystic Ovary Syndrome,
Endometriosis, Contraceptives, Menopause and Other Applications -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 62: Rest of Europe Historic Review for Women's Health
Therapeutics by Application - Postmenopausal Osteoporosis,
Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis,
Contraceptives, Menopause and Other Applications Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 63: Rest of Europe 15-Year Perspective for Women's Health
Therapeutics by Application - Percentage Breakdown of Value
Sales for Postmenopausal Osteoporosis, Hormonal Infertility,
Polycystic Ovary Syndrome, Endometriosis, Contraceptives,
Menopause and Other Applications for the Years 2012, 2020 &
2027

ASIA-PACIFIC
Table 64: Asia-Pacific Current & Future Analysis for Women's
Health Therapeutics by Geographic Region - Australia, India,
South Korea and Rest of Asia-Pacific Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2020 through
2027 and % CAGR

Table 65: Asia-Pacific Historic Review for Women's Health
Therapeutics by Geographic Region - Australia, India, South
Korea and Rest of Asia-Pacific Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 66: Asia-Pacific 15-Year Perspective for Women's Health
Therapeutics by Geographic Region - Percentage Breakdown of
Value Sales for Australia, India, South Korea and Rest of
Asia-Pacific Markets for Years 2012, 2020 & 2027

Table 67: Asia-Pacific Current & Future Analysis for Women's
Health Therapeutics by Application - Postmenopausal
Osteoporosis, Hormonal Infertility, Polycystic Ovary Syndrome,
Endometriosis, Contraceptives, Menopause and Other Applications -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 68: Asia-Pacific Historic Review for Women's Health
Therapeutics by Application - Postmenopausal Osteoporosis,
Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis,
Contraceptives, Menopause and Other Applications Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 69: Asia-Pacific 15-Year Perspective for Women's Health
Therapeutics by Application - Percentage Breakdown of Value
Sales for Postmenopausal Osteoporosis, Hormonal Infertility,
Polycystic Ovary Syndrome, Endometriosis, Contraceptives,
Menopause and Other Applications for the Years 2012, 2020 &
2027

AUSTRALIA
Table 70: Australia Current & Future Analysis for Women's
Health Therapeutics by Application - Postmenopausal
Osteoporosis, Hormonal Infertility, Polycystic Ovary Syndrome,
Endometriosis, Contraceptives, Menopause and Other Applications -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 71: Australia Historic Review for Women's Health
Therapeutics by Application - Postmenopausal Osteoporosis,
Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis,
Contraceptives, Menopause and Other Applications Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 72: Australia 15-Year Perspective for Women's Health
Therapeutics by Application - Percentage Breakdown of Value
Sales for Postmenopausal Osteoporosis, Hormonal Infertility,
Polycystic Ovary Syndrome, Endometriosis, Contraceptives,
Menopause and Other Applications for the Years 2012, 2020 &
2027

INDIA
Table 73: India Current & Future Analysis for Women's Health
Therapeutics by Application - Postmenopausal Osteoporosis,
Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis,
Contraceptives, Menopause and Other Applications - Independent
Analysis of Annual Sales in US$ Million for the Years 2020
through 2027 and % CAGR

Table 74: India Historic Review for Women's Health Therapeutics
by Application - Postmenopausal Osteoporosis, Hormonal
Infertility, Polycystic Ovary Syndrome, Endometriosis,
Contraceptives, Menopause and Other Applications Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 75: India 15-Year Perspective for Women's Health
Therapeutics by Application - Percentage Breakdown of Value
Sales for Postmenopausal Osteoporosis, Hormonal Infertility,
Polycystic Ovary Syndrome, Endometriosis, Contraceptives,
Menopause and Other Applications for the Years 2012, 2020 &
2027

SOUTH KOREA
Table 76: South Korea Current & Future Analysis for Women's
Health Therapeutics by Application - Postmenopausal
Osteoporosis, Hormonal Infertility, Polycystic Ovary Syndrome,
Endometriosis, Contraceptives, Menopause and Other Applications -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 77: South Korea Historic Review for Women's Health
Therapeutics by Application - Postmenopausal Osteoporosis,
Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis,
Contraceptives, Menopause and Other Applications Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 78: South Korea 15-Year Perspective for Women's Health
Therapeutics by Application - Percentage Breakdown of Value
Sales for Postmenopausal Osteoporosis, Hormonal Infertility,
Polycystic Ovary Syndrome, Endometriosis, Contraceptives,
Menopause and Other Applications for the Years 2012, 2020 &
2027

REST OF ASIA-PACIFIC
Table 79: Rest of Asia-Pacific Current & Future Analysis for
Women's Health Therapeutics by Application - Postmenopausal
Osteoporosis, Hormonal Infertility, Polycystic Ovary Syndrome,
Endometriosis, Contraceptives, Menopause and Other Applications -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 80: Rest of Asia-Pacific Historic Review for Women's
Health Therapeutics by Application - Postmenopausal
Osteoporosis, Hormonal Infertility, Polycystic Ovary Syndrome,
Endometriosis, Contraceptives, Menopause and Other Applications
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 81: Rest of Asia-Pacific 15-Year Perspective for Women's
Health Therapeutics by Application - Percentage Breakdown of
Value Sales for Postmenopausal Osteoporosis, Hormonal
Infertility, Polycystic Ovary Syndrome, Endometriosis,
Contraceptives, Menopause and Other Applications for the Years
2012, 2020 & 2027

LATIN AMERICA
Table 82: Latin America Current & Future Analysis for Women's
Health Therapeutics by Geographic Region - Argentina, Brazil,
Mexico and Rest of Latin America Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2020 through 2027 and
% CAGR

Table 83: Latin America Historic Review for Women's Health
Therapeutics by Geographic Region - Argentina, Brazil, Mexico
and Rest of Latin America Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2012 through 2019 and %
CAGR

Table 84: Latin America 15-Year Perspective for Women's Health
Therapeutics by Geographic Region - Percentage Breakdown of
Value Sales for Argentina, Brazil, Mexico and Rest of Latin
America Markets for Years 2012, 2020 & 2027

Table 85: Latin America Current & Future Analysis for Women's
Health Therapeutics by Application - Postmenopausal
Osteoporosis, Hormonal Infertility, Polycystic Ovary Syndrome,
Endometriosis, Contraceptives, Menopause and Other Applications -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 86: Latin America Historic Review for Women's Health
Therapeutics by Application - Postmenopausal Osteoporosis,
Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis,
Contraceptives, Menopause and Other Applications Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 87: Latin America 15-Year Perspective for Women's Health
Therapeutics by Application - Percentage Breakdown of Value
Sales for Postmenopausal Osteoporosis, Hormonal Infertility,
Polycystic Ovary Syndrome, Endometriosis, Contraceptives,
Menopause and Other Applications for the Years 2012, 2020 &
2027

ARGENTINA
Table 88: Argentina Current & Future Analysis for Women's
Health Therapeutics by Application - Postmenopausal
Osteoporosis, Hormonal Infertility, Polycystic Ovary Syndrome,
Endometriosis, Contraceptives, Menopause and Other Applications -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 89: Argentina Historic Review for Women's Health
Therapeutics by Application - Postmenopausal Osteoporosis,
Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis,
Contraceptives, Menopause and Other Applications Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 90: Argentina 15-Year Perspective for Women's Health
Therapeutics by Application - Percentage Breakdown of Value
Sales for Postmenopausal Osteoporosis, Hormonal Infertility,
Polycystic Ovary Syndrome, Endometriosis, Contraceptives,
Menopause and Other Applications for the Years 2012, 2020 &
2027

BRAZIL
Table 91: Brazil Current & Future Analysis for Women's Health
Therapeutics by Application - Postmenopausal Osteoporosis,
Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis,
Contraceptives, Menopause and Other Applications - Independent
Analysis of Annual Sales in US$ Million for the Years 2020
through 2027 and % CAGR

Table 92: Brazil Historic Review for Women's Health
Therapeutics by Application - Postmenopausal Osteoporosis,
Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis,
Contraceptives, Menopause and Other Applications Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 93: Brazil 15-Year Perspective for Women's Health
Therapeutics by Application - Percentage Breakdown of Value
Sales for Postmenopausal Osteoporosis, Hormonal Infertility,
Polycystic Ovary Syndrome, Endometriosis, Contraceptives,
Menopause and Other Applications for the Years 2012, 2020 &
2027

MEXICO
Table 94: Mexico Current & Future Analysis for Women's Health
Therapeutics by Application - Postmenopausal Osteoporosis,
Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis,
Contraceptives, Menopause and Other Applications - Independent
Analysis of Annual Sales in US$ Million for the Years 2020
through 2027 and % CAGR

Table 95: Mexico Historic Review for Women's Health
Therapeutics by Application - Postmenopausal Osteoporosis,
Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis,
Contraceptives, Menopause and Other Applications Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 96: Mexico 15-Year Perspective for Women's Health
Therapeutics by Application - Percentage Breakdown of Value
Sales for Postmenopausal Osteoporosis, Hormonal Infertility,
Polycystic Ovary Syndrome, Endometriosis, Contraceptives,
Menopause and Other Applications for the Years 2012, 2020 &
2027

REST OF LATIN AMERICA
Table 97: Rest of Latin America Current & Future Analysis for
Women's Health Therapeutics by Application - Postmenopausal
Osteoporosis, Hormonal Infertility, Polycystic Ovary Syndrome,
Endometriosis, Contraceptives, Menopause and Other Applications -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 98: Rest of Latin America Historic Review for Women's
Health Therapeutics by Application - Postmenopausal
Osteoporosis, Hormonal Infertility, Polycystic Ovary Syndrome,
Endometriosis, Contraceptives, Menopause and Other Applications
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 99: Rest of Latin America 15-Year Perspective for Women's
Health Therapeutics by Application - Percentage Breakdown of
Value Sales for Postmenopausal Osteoporosis, Hormonal
Infertility, Polycystic Ovary Syndrome, Endometriosis,
Contraceptives, Menopause and Other Applications for the Years
2012, 2020 & 2027

MIDDLE EAST
Table 100: Middle East Current & Future Analysis for Women's
Health Therapeutics by Geographic Region - Iran, Israel, Saudi
Arabia, UAE and Rest of Middle East Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2020 through
2027 and % CAGR

Table 101: Middle East Historic Review for Women's Health
Therapeutics by Geographic Region - Iran, Israel, Saudi Arabia,
UAE and Rest of Middle East Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2012 through 2019 and %
CAGR

Table 102: Middle East 15-Year Perspective for Women's Health
Therapeutics by Geographic Region - Percentage Breakdown of
Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of
Middle East Markets for Years 2012, 2020 & 2027

Table 103: Middle East Current & Future Analysis for Women's
Health Therapeutics by Application - Postmenopausal
Osteoporosis, Hormonal Infertility, Polycystic Ovary Syndrome,
Endometriosis, Contraceptives, Menopause and Other Applications -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 104: Middle East Historic Review for Women's Health
Therapeutics by Application - Postmenopausal Osteoporosis,
Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis,
Contraceptives, Menopause and Other Applications Markets -
Independent Analysis of Annual Sales in US$ Million for Years

Please contact our Customer Support Center to get the complete Table of Contents